http://researchonline.federation.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14820 Wed 25 Nov 2020 14:15:41 AEDT ]]> Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14735 Wed 07 Apr 2021 14:02:49 AEST ]]> A role for MAIT cells in colorectal cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14575 Wed 07 Apr 2021 14:02:39 AEST ]]> Ovarian cancer, cancer stem cells and current treatment strategies : a potential role of magmas in the current treatment methods http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14469 Wed 07 Apr 2021 14:02:33 AEST ]]> Foxp3+ tregs from langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14448 Wed 07 Apr 2021 14:02:32 AEST ]]> Polyclonal T-Cells Express CD1a in Langerhans Cell Histiocytosis (LCH) Lesions http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13938 Wed 07 Apr 2021 14:02:02 AEST ]]> Paclitaxel-induced Src activation is inhibited by dasatinib treatment, independently of cancer stem cell properties, in a mouse model of ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13849 Wed 07 Apr 2021 14:01:57 AEST ]]> Altered populations of unconventional T Cell lineages in patients with Langerhans Cell Histiocytosis http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13529 Wed 07 Apr 2021 14:01:39 AEST ]]> Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells : Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13504 Wed 07 Apr 2021 14:01:38 AEST ]]> A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13384 Wed 07 Apr 2021 14:01:32 AEST ]]> Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13084 Wed 07 Apr 2021 14:01:16 AEST ]]> The many facets of metzincins and their endogenous inhibitors : Perspectives on ovarian cancer progression http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13055 Wed 07 Apr 2021 14:01:15 AEST ]]> Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:11406 Wed 07 Apr 2021 13:56:43 AEST ]]> A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10998 Wed 07 Apr 2021 13:56:19 AEST ]]> Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10794 Wed 07 Apr 2021 13:56:09 AEST ]]> Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10784 Wed 07 Apr 2021 13:56:08 AEST ]]> An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10523 Wed 07 Apr 2021 13:55:51 AEST ]]> Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10297 Wed 07 Apr 2021 13:55:38 AEST ]]> EVERSUN : A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10146 = 22 weeks of alternating therapy; 78% received >= 22 weeks of any treatment. PFS6m was 29/55 (53%; 95% confidence interval [CI] 40% to 66%). Tumour response rate was 7/55 (13%; 95% CI 4% to 22%, all partial responses). After median follow-up of 20 months, 47 of 55 (86%) had progressed with a median progression-free survival of 8 months (95% CI 5-10), and 30 of 55 (55%) had died with a median OS of 17 months (95% CI 12-undefined). AEs were consistent with those expected for each single agent. No convincing prognostic biomarkers were identified. Conclusions: The EVERSUN regimen was feasible and safe, but its activity did not meet pre-specified values to warrant further research. This supports the current approach of continuing anti-VEGF therapy until progression or prohibitive toxicity before changing treatment.]]> Wed 07 Apr 2021 13:55:28 AEST ]]> Acute exercise leads to regulation of Telomere-Associated genes and MicroRNA expression in immune Cells http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:5804 Wed 07 Apr 2021 13:45:22 AEST ]]> Risk for septic death in severe congenital neutropenia http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:1694 Wed 07 Apr 2021 13:32:47 AEST ]]> Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:745 Wed 07 Apr 2021 13:31:43 AEST ]]> Glycogen storage disease http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:462 Wed 07 Apr 2021 13:31:22 AEST ]]> A time to kill : Viral manipulation of the cell death program http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:394 Wed 07 Apr 2021 13:31:17 AEST ]]> Severe chronic neutropenia : Treatment and follow-up of patients in the severe chronic neutropenia international registry http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:222 Wed 07 Apr 2021 13:31:05 AEST ]]> Cyclic neutropenia is not associated with transformation to MDS and AML http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:221 Wed 07 Apr 2021 13:31:05 AEST ]]> Predictors of transformation to myelodysplasia/acute myelogenous leukemia (MDS/AML) in severe congenital neutropenia (CN) http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:127 Wed 07 Apr 2021 13:30:57 AEST ]]> Severe chronic idiopathic neutropenia in adults : Long-term follow-up of 358 patients http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:122 Wed 07 Apr 2021 13:30:57 AEST ]]> Langerhans cell histiocytosis : a malignant myeloid neoplasm or disorder of immune regulation? http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15475 Tue 30 Nov 2021 13:35:11 AEDT ]]> Crosstalk between immune checkpoint modulators, metabolic reprogramming and cellular plasticity in triple-negative breast cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17742 Tue 16 May 2023 12:37:14 AEST ]]> The Interleukin-11/IL-11 receptor promotes glioblastoma survival and invasion under glucose-starved conditions through enhanced glutaminolysis http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:18184 Tue 15 Aug 2023 14:11:58 AEST ]]> In vitro and in silico analysis of epithelial-mesenchymal transition and cancer stemness as prognostic markers of clear cell renal cell carcinoma http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:18577 Tue 14 Nov 2023 12:06:18 AEDT ]]> Plasma signaling factors in patients with langerhans cell histiocytosis (LCH) correlate with relative frequencies of LCH cells and t cells within lesions http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17807 Thu 25 May 2023 10:28:08 AEST ]]> Precision medicine : an optimal approach to patient care in renal cell carcinoma http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17462 Thu 23 Mar 2023 11:48:07 AEDT ]]> Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17967 Thu 22 Jun 2023 13:21:23 AEST ]]> Does CD1a expression influence T cell function in patients with langerhans cell histiocytosis? http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:16093 Thu 19 May 2022 10:08:59 AEST ]]> Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15773 Thu 17 Mar 2022 11:20:05 AEDT ]]> A three-stage developmental pathway for human V http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:18730 Thu 14 Dec 2023 10:11:20 AEDT ]]> Expression of TIMPs and MMPs in ovarian tumors, ascites, ascites-derived cells, and cancer cell lines : characteristic modulatory response before and after chemotherapy treatment http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:16913 Thu 01 Dec 2022 11:58:10 AEDT ]]> Prognostic role of immune checkpoint regulators in cholangiocarcinoma : a pilot study http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15343 Mon 25 Oct 2021 12:16:10 AEDT ]]> The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15336 Mon 25 Oct 2021 11:55:11 AEDT ]]> Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17730 Mon 15 May 2023 11:18:12 AEST ]]> Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15520 Mon 13 Dec 2021 15:39:11 AEDT ]]>